Skip to main
NBRVF
NBRVF logo

Nabriva Therapeutics PLC (NBRVF)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy NBRVF Stock

About Nabriva Therapeutics PLC (NBRVF)

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Market cap$300
Yesterday's volume395
Revenue (TTM)
Avg. daily volume310.89
EBITDA (TTM)
Open$0.00
Price / earnings ratio
Yesterday's range$0 - $0
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)-5188.75x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for NBRVF stock is $300

The 52-week high for NBRVF stock is $0.01. The current NBRVF stock price $undefined is 100.00% below its 52-week high

No, the NBRVF stock does not pay dividends to its shareholders

How to buy NBRVF stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NBRVF stock

    Navigate to the Explore page. Then, type NBRVF into the search bar. When you see NBRVF stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NBRVF stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy NBRVF Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.